We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
561 hedge funds and large institutions have $26B invested in Alexion Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 220 increasing their positions, 204 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 61
2% more funds holding
Funds holding: 548 → 561 (+13)
8% more repeat investments, than reductions
Existing positions increased: 220 | Existing positions reduced: 204
2% more call options, than puts
Call options by funds: $261M | Put options by funds: $257M
3% less capital invested
Capital invested by funds: $26.9B → $26B (-$932M)
29% less funds holding in top 10
Funds holding in top 10: 24 → 17 (-7)
Holders
561
Holders Change
+13
Holders Change %
+2.37%
% of All Funds
13.97%
Holding in Top 10
17
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-29.17%
% of All Funds
0.42%
New
84
Increased
220
Reduced
204
Closed
61
Calls
$261M
Puts
$257M
Net Calls
+$4.33M
Net Calls Change
+$22.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$2.32B |
| 2 |
JP Morgan Chase
New York
|
+$175M |
| 3 |
Jennison Associates
New York
|
+$174M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$128M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$122M |
